August 30, 2021
Via: Natalie DunnThe ongoing COVID-19 pandemic has sparked an unprecedented crisis for governments, healthcare providers, and industries across the world. Biopharmaceutical companies were especially affected, as they were left struggling to develop solutions that will ultimately help diagnose and treat those suffering […]
July 30, 2021
Via: Natalie DunnThe Delta variant of the coronavirus has become the dominant strain around the world, bringing with it an increase in deaths in the US and many other countries. While the victims are almost exclusively unvaccinated, the new surge seems to […]
June 30, 2021
Via: David DicksonIn 1982, the U.S. approved human insulin—the first ever recombinant biopharmaceutical drug. Since then, biopharma development has proceeded at an exponential pace, with new innovations redefining, over and over again, the possibilities of medicine. Going forward, biopharma will demand more […]
May 28, 2021
Via: Natalie DunnWith COVID-19 vaccines becoming more widely available around the world, and countries everywhere easing restrictions, a return to normal is now on everyone’s mind. While many activities are still recovering and regulations remain an important part of our daily lives, […]
April 30, 2021
Via: Rachel OldfordBiopharmaceuticals are among the most complex and elegant realizations of modern science. But this complexity also comes at great cost. More exactly, biotech-manufacturing facilities need between $200 and $500 million to be built and this process could last up to […]
September 17, 2021
September 16, 2021
August 26, 2021
August 24, 2021
September 16, 2021
September 2, 2021
Copyright © 2021. All rights reserved
